This proposed rule makes amendments for SSB 5610 chapter 228, Laws of 2022 which permits third party cost-sharing for prescription drugs within specific parameters. The rule will also establish consistency in applying payments. Amendments to rules are made for consistency in definitions with a third-party payment, clarity in pharmacy exceptions and the appeals process, and the application of cost-sharing paid by a third party for the purposes of high-deductible plans. This rulemaking will be addressed in accordance with federal guidance.
Adopted rule
Proposed rulemaking filed Aug. 23, 2022
Public hearing held Sept. 28, 2022
Interested parties meeting held July 12, 2022
Prepublication draft released June 30, 2022
Notice to start rulemaking filed June 9, 2022
Comments
- Comments are no longer being accepted for this rule
- View previously submitted comments